SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech firesales -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (2882)2/17/2012 9:21:08 AM
From: Jibacoa  Read Replies (1) | Respond to of 3661
 
GILD on pre-market trading, after announcing that patients with Hepatitis C genotype 1 relapsed within 4 weeks of completing 12 weeks of treatment with GS-7977 plus ribavirin (RBV).
bigcharts.marketwatch.com symb=GILD&insttype=&freq=1&show=&time=6&x=17&y=15

Bernard